The LC3+ EVs levels in different samples including tumor cell supernatants, peripheral blood of TB mouse models before and after immune therapy, and breast cancer patients with different subtypes and stages were determined with the electrochemical immunosensor. This evidence concerns the gene MAP1LC3A and neoplasm.